Long Jiang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Squamous Cell Carcinoma

Dna Damage Response

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan, Linnéa Påvénius, Jessica Hacheney, Long Jiang, Silke Eisinger, Danai Lianoudaki, Dilraj Lama, Francisca Castillo, Cecilia Bosdotter, Warren W Kretzschmar, Omayma Al-Radi, Nicolas Fritz, Eduardo J Villablanca, Mikael C I Karlsson, Fredrik Wermeling, Marika Nestor, David P Lane, Saikiran K Sedimbi
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy. Cancer research communications 2 (9) (2022)
Long Jiang, Katrine Ingelshed, Yunbing Shen, Sanjaykumar V Boddul, Vaishnavi Srinivasan Iyer, Zsolt Kasza, Saikiran K Sedimbi, David P Lane, Fredrik Wermeling
CRISPR/Cas9-induced DNA damage enriches for mutations in a p53-linked interactome: implications for CRISPR-based therapies. Cancer research (2021)
Sudeepta Kumar Panda, Gustaf Wigerblad, Long Jiang, Yanek Jiménez-Andrade, Vaishnavi Srinivasan Iyer, Yunbing Shen, Sanjaykumar V Boddul, Andre Ortlieb Guerreiro-Cacais, Bruno Raposo, Zsolt Kasza, Fredrik Wermeling
IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints. Proceedings of the National Academy of Sciences of the United States of America 117 (6) (2020)